Condition

GFAP clinical trials and research

As of November 12, 2026, Find a Trial lists 3 GFAP clinical trials that are recruiting, at sites in 3 countries (most in Austria (1), France (1), Brazil (1)). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.

Newest GFAP clinical trials

StudyPhaseWhereStatusRegistered
How vegan, vegetarian, or omnivorous diets relate to blood levels of brain proteins NfL and GFAP — Salzburg, State of Salzburg Recruiting Dec 31, 2025
Medium-term outcomes of treatments for antibody-associated autoimmune encephalitis — Bron Recruiting Aug 20, 2025
Using brain stimulation and digital training to improve cognitive function in older adults — Rio de Janeiro, Rio de Janeiro Recruiting Dec 13, 2024

All recruiting trials (3)

Related topics

Alzheimer DiseaseBeta-AmyloidCognitive DeclineCognitive DysfunctionDementiaDementia, VascularFrontotemporal DegenerationLewy Body DiseaseMild Cognitive Impairment

Quick answers

How many GFAP clinical trials are recruiting right now?

3, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 3 countries. The most sites are in Austria (1 trial), France (1 trial), Brazil (1 trial). Each study page lists its sites and which ones are recruiting.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →

Last reviewed 2026-11-12 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.